Last month, former President Joe Biden announced that he had been diagnosed with an aggressive form of prostate cancer. The news sparked a larger conversation about what exactly the best practices are to screen for prostate cancer. Turns out, it’s more complicated than it might seem. Host Ira Flatow is joined by oncologist Matthew Cooperberg and statistician Andrew Vickers, who studies prostate cancer screening, to help unpack those complexities.Guests:Dr. Matthew Cooperberg is a urologic oncologist and professor at the University of California, San Francisco.Dr. Andrew Vickers is a statistician who studies the efficacy of prostate cancer screening at Memorial Sloan Kettering Cancer Center based in New York City.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.